CN1661011A - 一种重组人血小板衍生生长因子及其编码基因与表达方法 - Google Patents
一种重组人血小板衍生生长因子及其编码基因与表达方法 Download PDFInfo
- Publication number
- CN1661011A CN1661011A CN 200410068993 CN200410068993A CN1661011A CN 1661011 A CN1661011 A CN 1661011A CN 200410068993 CN200410068993 CN 200410068993 CN 200410068993 A CN200410068993 A CN 200410068993A CN 1661011 A CN1661011 A CN 1661011A
- Authority
- CN
- China
- Prior art keywords
- growth factor
- seq
- pdgf
- human blood
- blood platelet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 41
- 210000001772 blood platelet Anatomy 0.000 title claims abstract description 30
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 28
- 239000003102 growth factor Substances 0.000 title claims abstract description 24
- 230000014509 gene expression Effects 0.000 title abstract description 48
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 11
- 229920001184 polypeptide Polymers 0.000 claims abstract description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 10
- 239000000539 dimer Substances 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- 241000235058 Komagataella pastoris Species 0.000 claims description 9
- 239000013604 expression vector Substances 0.000 claims description 9
- 210000004962 mammalian cell Anatomy 0.000 claims description 7
- 238000003259 recombinant expression Methods 0.000 claims description 6
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 claims description 4
- 241000699802 Cricetulus griseus Species 0.000 claims description 4
- 101150074155 DHFR gene Proteins 0.000 claims description 4
- 241001506991 Komagataella phaffii GS115 Species 0.000 claims description 4
- 230000000968 intestinal effect Effects 0.000 claims description 4
- 210000001672 ovary Anatomy 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 241000238631 Hexapoda Species 0.000 claims description 3
- 230000008034 disappearance Effects 0.000 claims description 3
- 238000009396 hybridization Methods 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 108091033319 polynucleotide Proteins 0.000 claims description 2
- 102000040430 polynucleotide Human genes 0.000 claims description 2
- 239000002157 polynucleotide Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 108010081589 Becaplermin Proteins 0.000 description 25
- 150000001413 amino acids Chemical class 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000004071 biological effect Effects 0.000 description 12
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 10
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 9
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 8
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 244000286779 Hansenula anomala Species 0.000 description 7
- 235000014683 Hansenula anomala Nutrition 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 5
- 238000004153 renaturation Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000006052 feed supplement Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000003226 mitogen Substances 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016362 Catenins Human genes 0.000 description 1
- 108010067316 Catenins Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150051118 PTM1 gene Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 101150099105 alien gene Proteins 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000001755 duct epithelial cell Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 108010017843 platelet-derived growth factor A Proteins 0.000 description 1
- 108010000685 platelet-derived growth factor AB Proteins 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108700021652 sis Genes Proteins 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100689932A CN100503826C (zh) | 2003-07-21 | 2004-07-15 | 一种重组人血小板衍生生长因子及其编码基因与表达方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN03150201.6 | 2003-07-21 | ||
CN03150201 | 2003-07-21 | ||
CNB2004100689932A CN100503826C (zh) | 2003-07-21 | 2004-07-15 | 一种重组人血小板衍生生长因子及其编码基因与表达方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1661011A true CN1661011A (zh) | 2005-08-31 |
CN100503826C CN100503826C (zh) | 2009-06-24 |
Family
ID=35010563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100689932A Expired - Lifetime CN100503826C (zh) | 2003-07-21 | 2004-07-15 | 一种重组人血小板衍生生长因子及其编码基因与表达方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100503826C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100356977C (zh) * | 2005-11-29 | 2007-12-26 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种重组人血小板衍生生长因子凝胶剂 |
CN102154305A (zh) * | 2011-01-17 | 2011-08-17 | 中国科学院广州生物医药与健康研究院 | 一种人血小板源性生长因子a同源二聚体及其生成方法 |
CN105085652A (zh) * | 2014-05-16 | 2015-11-25 | 中国人民解放军军事医学科学院生物工程研究所 | 血小板衍生生长因子b突变体、其制备方法及用途 |
CN108949870A (zh) * | 2018-08-06 | 2018-12-07 | 苏州锐妥欣生物技术有限公司 | 一种生产重血小板源生长因子的方法 |
-
2004
- 2004-07-15 CN CNB2004100689932A patent/CN100503826C/zh not_active Expired - Lifetime
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100356977C (zh) * | 2005-11-29 | 2007-12-26 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种重组人血小板衍生生长因子凝胶剂 |
CN102154305A (zh) * | 2011-01-17 | 2011-08-17 | 中国科学院广州生物医药与健康研究院 | 一种人血小板源性生长因子a同源二聚体及其生成方法 |
CN105085652A (zh) * | 2014-05-16 | 2015-11-25 | 中国人民解放军军事医学科学院生物工程研究所 | 血小板衍生生长因子b突变体、其制备方法及用途 |
WO2015172752A3 (zh) * | 2014-05-16 | 2015-12-30 | 中国人民解放军军事医学科学院生物工程研究所 | 血小板衍生生长因子b突变体、其制备方法及用途 |
JP2018525967A (ja) * | 2014-05-16 | 2018-09-13 | インスティテュート オブ バイオテクノロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー.エル.エー.チャイナ | 血小板由来増殖因子b変異体、その製造方法及びその使用 |
US10450358B2 (en) | 2014-05-16 | 2019-10-22 | Institute Of Biotechnology Academy Of Military Medical Sciences P.L.A. China | Platelet-derived growth factor B mutant, preparation method therefor and use thereof |
AU2015258537B2 (en) * | 2014-05-16 | 2020-05-14 | Institute Of Biotechnology Academy Of Military Medical Sciences P.L.A. China | Platelet-derived growth factor B mutant, preparation method therefor, and use thereof |
CN105085652B (zh) * | 2014-05-16 | 2021-06-22 | 中国人民解放军军事医学科学院生物工程研究所 | 血小板衍生生长因子b突变体、其制备方法及用途 |
CN108949870A (zh) * | 2018-08-06 | 2018-12-07 | 苏州锐妥欣生物技术有限公司 | 一种生产重血小板源生长因子的方法 |
CN108949870B (zh) * | 2018-08-06 | 2021-05-28 | 智享生物(苏州)有限公司 | 一种生产重组血小板源生长因子的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100503826C (zh) | 2009-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1047204C (zh) | 生产重组人体乳铁蛋白 | |
CN1020473C (zh) | 编码表现有人粒性巨噬细胞和嗜伊红细胞生长因子活性之多肽的cDNA克隆 | |
CA2296071C (en) | Production and use of recombinant protein multimers with altered biological activity | |
CN1405182A (zh) | 血清白蛋白与粒细胞集落刺激因子的融合蛋白 | |
CN101514229B (zh) | 人干扰素α衍生物及其聚乙二醇化修饰物 | |
CN1766107A (zh) | 一种重组人角质细胞生长因子的生产方法 | |
CN100503826C (zh) | 一种重组人血小板衍生生长因子及其编码基因与表达方法 | |
CN101875699B (zh) | 人表皮生长因子和金属硫蛋白的融合蛋白及其制备方法和应用 | |
CN1873006A (zh) | 一种重组人胰岛素原的生产方法 | |
CN100344758C (zh) | 中国对虾含单一乳清酸性蛋白结构域的抗菌肽基因及其所编码的抗菌肽与应用 | |
CN101037692A (zh) | 利用植物油体表达人胰岛素的方法 | |
CN1191271C (zh) | 干扰素-胸腺肽融合蛋白及其制法 | |
CN1962873A (zh) | 一种IFN-λ1的表达方法及其专用表达载体和工程菌 | |
CN1033759C (zh) | 猪生长激素类似物 | |
CN1818068A (zh) | 重组人白细胞介素-2(125ser)表达载体的构建 | |
CN101067138A (zh) | 基因工程制备人毛乳头细胞hspc016蛋白质的方法、表达载体和工程菌 | |
CN1854296A (zh) | 重组人干扰素β的生产方法 | |
CN1974767A (zh) | 猪表皮生长因子基因及其应用 | |
CN1405305A (zh) | 一种高效、广谱角蛋白酶及其基因 | |
CN110317821A (zh) | 一种融合蛋白thg及其应用 | |
CN108794645A (zh) | 一种由牛白蛋白、牛干扰素γ和牛干扰素α组成的融合蛋白及其制备方法 | |
CN1523040A (zh) | 人胸腺素α1与人复合干扰素的融合蛋白及其制备 | |
CN110240642B (zh) | 新型胸腺肽 | |
Canals et al. | Cloning and expression of bovine interleukin-15: analysis and modulation of transcription by exogenous stimulation | |
CN1876817A (zh) | 一种人肿瘤坏死因子TNF-α突变体的生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BIOENGINEERING INST., ACADEMY OF MILITARY MEDICAL Free format text: FORMER OWNER: MICROBE EPIDEMIC DISEASE RESEARCH INST. OF MILITARY MEDICAL SCIENCES ACADEMY (CN Effective date: 20130313 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130313 Address after: 100071 Fengtai District East Street, No. 20, Beijing Patentee after: INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, CHINA Patentee after: Beijing Jinbang Bioengineering Co.,Ltd. Address before: 100071 Institute of microbial epidemiology, military medical college, No. 20 East Main Street, Beijing, Fengtai District Patentee before: Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, PR China Patentee before: Beijing Jinbang Bioengineering Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Zhang Liting Document name: Notification that Application Deemed not to be Proposed |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING ZHONGHONG SAISI BIOLOGICAL TECHNOLOGY CO., Free format text: FORMER OWNER: BEIJING JINBANG BIOTECHNOLOGY TECHNOLOGY CO., LTD. Effective date: 20140227 |
|
CP01 | Change in the name or title of a patent holder |
Address after: 100071 Fengtai District East Street, No. 20, Beijing Patentee after: INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, CHINA Patentee after: Beijing Jin Bang Biotechnology Co.,Ltd. Address before: 100071 Fengtai District East Street, No. 20, Beijing Patentee before: INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, CHINA Patentee before: Beijing Jinbang Bioengineering Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140227 Address after: 100071 Fengtai District East Street, No. 20, Beijing Patentee after: INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, CHINA Patentee after: Beijing Zhonghong Saisi Biotechnology Co.,Ltd. Address before: 100071 Fengtai District East Street, No. 20, Beijing Patentee before: INSTITUTE OF BIOTECHNOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, CHINA Patentee before: Beijing Jin Bang Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20090624 |